In the current research, we hypothesized that BARX2 downregulates KRT16 expression to modulate the Ras signaling pathway and that BARX2 is linked to the suppression of NPC carcinogenesis. This evidence concerns the gene KRT16 and nasopharyngeal carcinoma.